Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II

Business combination with Silver Spike Acquisition Corp. II (Nasdaq: SPKB) expected to generate gross proceeds of up to $288 million and implies a combined enterprise value of $446 million Eleusis

Related Keywords

New York ,United States ,Toronto ,Ontario ,Canada ,Shlomi Raz ,Alan Oshiki ,Abernathy Macgregor ,Robert Hershberg ,Alex Speiser ,Orrin Devinsky ,Kostenloser Wertpapierhandel ,John Tucker ,Scott Gordon ,Canaccord Genuity ,School Of Medicine ,Eleusis Holdings Limited ,Credit Suisse Securities United States ,Nasdaq ,Braun ,Regulatory Agency Innovative Licensing ,Silver Spike Or Eleusis Inc ,Cantor Fitzgerald Co ,Latham Watkins ,Davis Polk Wardwell ,Wh Holdings ,Sc Pharmaceuticals ,Boom Associates ,Silver Spike Acquisition Corp ,Exchange Commission ,Corporate Development ,Wm Holding Company ,Silver Spike Alternative Health Partners Fund ,Phathom Pharmaceuticals ,Eleusis Inc ,Langone Comprehensive Epilepsy Center ,Silver Spike Acquisition ,Innovation Passport Designation ,Regulatory Agency ,Innovative Licensing ,Access Pathway ,Silver Spike Capital ,Silver Spike ,David Socks ,Managing Partner ,Suisse Securities ,Cantor Fitzgerald ,Comprehensive Epilepsy Center ,Medical Advisory Board ,Spike Capital ,Nasdaq Capital Market ,Quarterly Reports ,Investor Contacts ,Corporate Development Director ,Capital Formation ,Will Braun ,Psychedelic ,Science ,Leader ,Eleusis ,Become ,Public ,Company ,Berger ,Silver ,Spike ,Cquisition ,Orp ,